Gold Nanoparticle Platforms Enabling Targeted Cancer Imaging and Treatment
DOI:
https://doi.org/10.62051/hg816k34Keywords:
Gold nanoparticles; cancer theranostics; computed tomography imaging; photothermal therapy; clinical translation.Abstract
Gold nanoparticles (AuNPs) combine a high atomic number with tunable surface plasmon resonance, enabling both diagnostic and therapeutic applications in cancer. Their strong X-ray attenuation provides excellent contrast for computed tomography, while near-infrared (NIR) plasmonic absorption allows efficient photothermal conversion for tumour ablation. Versatile surface chemistry supports precise control over size, shape and ligand functionalisation, which governs biodistribution, cellular uptake and therapeutic performance. Clinical pilot studies have shown promising outcomes in focal tumour imaging and minimally invasive photothermal therapy (PTT), and nucleic acid–grafted AuNPs have demonstrated the ability to cross the blood–brain barrier for gene regulation. Despite these advances, key translational challenges remain, including the need for predictable long-term clearance, scalable synthesis with consistent quality, and well-defined regulatory standards. This review summarises current synthesis strategies, critical physicochemical properties and representative biomedical applications of AuNPs, and highlights design principles that will be essential for achieving safe and reproducible clinical deployment.
Downloads
References
[1] Bray F, Laversanne M, Weiderpass E, Soerjomataram I. The ever-increasing importance of cancer as a leading cause of premature death worldwide. Cancer, 2021, 127(16): 3029-3030.
[2] Kus-liśkiewicz M, Fickers P, Ben Tahar I. Biocompatibility and cytotoxicity of gold nanoparticles: recent advances in methodologies and regulations. International Journal of Molecular Sciences, 2021, 22(20): 10952.
[3] Hammami I, Alabdallah N M, Jomaa A Al, Kamoun M. Gold nanoparticles: synthesis properties and applications. Journal of King Saud University-Science, 2021, 33(7): 101560.
[4] Georgeous J, AlSawaftah N, Abuwatfa W H, Husseini G A. Review of gold nanoparticles: synthesis, properties, shapes, cellular uptake, targeting, release mechanisms and applications in drug delivery and therapy. Pharmaceutics, 2024, 16(10): 1332.
[5] Chen H, Shao L, Li Q, Wang J. Gold nanorods and their plasmonic properties. Chemical Society Reviews, 2013, 42(7): 2679-2724.
[6] Pereira A C, Oliveira A E F, Resende M A C, Ferreira L F. Investigation of the gold nanoparticles synthesis, mechanism and characterization using the Turkevich method. Preprints, 2023.
[7] Cai Q Y, Kim S H, Choi K S, Kim S Y, Byun S J, Kim K W, Park S H, Juhng S K, Yoon K H. Colloidal gold nanoparticles as a blood-pool contrast agent for x-ray computed tomography in mice. Investigative Radiology, 2007, 42(12): 797-806.
[8] Taylor M L, Wilson R E, Amrhein K D, Huang X. Gold nanorod-assisted photothermal therapy and improvement strategies. Bioengineering, 2022, 9(5): 200.
[9] Riley R S, Day E S. Gold nanoparticle-mediated photothermal therapy: applications and opportunities for multimodal cancer treatment. Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology, 2017, 9(4): e1449.
[10] Ghaffarlou M, Rashidzadeh H, Mohammadi A, Mousazadeh N, Barsbay M, Sharafi A, Gharbavi M, Danafar H, Javani S. Photothermal and radiotherapy with alginate-coated gold nanoparticles for breast cancer treatment. Scientific Reports, 2024, 14(1): 1-12.
[11] Rastinehad A R, Anastos H, Wajswol E, Winoker J S, Sfakianos J P, Doppalapudi S K, Carrick M R, Knauer C J, Taouli B, Lewis S C, Tewari A K, Schwartz J A, Canfield S E, George A K, West J L, Halas N J. Gold nanoshell-localized photothermal ablation of prostate tumors in a clinical pilot device study. Proceedings of the National Academy of Sciences, 2019, 116(37): 18590-18596.
[12] Kadria-Vili Y, Schwartz J A, Polascik T J, Goodrich G P, Jorden D, Pinder D, Halas N J, Rastinehad A R. A detailed clinical case of localized prostate tumors treated with nanoparticle-assisted sub-ablative laser ablation. Nanomaterials, 2024, 14(15): 1261.
[13] Jensen S A, Day E S, Ko C H, Hurley L A, Luciano J P, Kouri F M, Merkel T J, Luthi A C, Patel P C, Cutler J I, Daniel W L, Scott A W, Rotz M W, Meade T J, Giljohann D A, Mirkin C A, Stegh A H. Spherical nucleic acid nanoparticle conjugates as an RNAi-based therapy for glioblastoma. Science Translational Medicine, 2013, 5(209): 209ra152.
[14] Kumthekar P, Ko C H, Paunesku T, et al. A first-in-human phase 0 clinical study of RNA interference–based spherical nucleic acids in patients with recurrent glioblastoma. Science Translational Medicine, 2021, 13(584): eabb3945.
[15] Musazzi U M, Franzè S, Condorelli F, Minghetti P, Caliceti P. Feeding next-generation nanomedicines to Europe: regulatory and quality challenges. Advanced Healthcare Materials, 2023, 12(30): 2301956.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Transactions on Environment, Energy and Earth Sciences
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
